Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kyriakou C et al. – AlloSCT represents a valid therapeutic option for patients with AITL. Both the lower RR after transplantation as well as the decreased RR in patients developing cGVHD after the alloSCT suggests the existence of a clinically relevant graft–versus–lymphoma effect.

Related Articles

Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy
International Journal of Hematology, 12/01/09    Relevance Score: 94%

Anaplastic large cell lymphoma in a patient with rheumatoid arthritis
Rheumatology International, 11/10/09    Relevance Score: 91%

Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
British Journal of Haematology, 11/04/09    Relevance Score: 91%

Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma
Blood, 11/02/09    Relevance Score: 91%

Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations
British Journal of Haematology, 11/23/09    Relevance Score: 90%

Today in Leukemia/Lymphoma...keeping you current

Evaluation of childhood acute leukemia incidence and underreporting in Brazil by capture-recapture methodology
Cancer Epidemiology, 12/08/09

Is there a role for intensifying induction therapy in acute myeloid leukaemia (AML)?
Best Practice & Research: Clinical Haematology , 12/08/09

New agents for AML and MDS
Best Practice & Research: Clinical Haematology , 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address